Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. (Record no. 18721837)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02156 a2200649 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515162737.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200908s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1569-8041 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1093/annonc/mdn786 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Cohen, S J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20090825 |
| 245 00 - TITLE STATEMENT | |
| Title | Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Annals of oncology : official journal of the European Society for Medical Oncology |
| Date of publication, distribution, etc. | Jul 2009 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1223-9 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bevacizumab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Camptothecin |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Colorectal Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Progression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Irinotecan |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Metastasis |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplastic Cells, Circulating |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Organoplatinum Compounds |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oxaliplatin |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Predictive Value of Tests |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Rate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Time Factors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Punt, C J A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Iannotti, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Saidman, B H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sabbath, K D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gabrail, N Y |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Picus, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Morse, M A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mitchell, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Miller, M C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Doyle, G V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tissing, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Terstappen, L W M M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Meropol, N J |
| 773 0# - HOST ITEM ENTRY | |
| Title | Annals of oncology : official journal of the European Society for Medical Oncology |
| Related parts | vol. 20 |
| -- | no. 7 |
| -- | p. 1223-9 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1093/annonc/mdn786">https://doi.org/10.1093/annonc/mdn786</a> |
| Public note | Available from publisher's website |
No items available.